Structural Heart Imaging Market
Report ID: SQMIG35G2430
Report ID: SQMIG35G2430
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35G2430 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
153
|Figures:
78
Global Structural Heart Imaging Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.18 Billion in 2025 to USD 17.76 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
A worldwide prominent demographic shift and increasing incidence of valvular and congenital heart diseases among the aging population are pushing the structural heart imaging market, leading to a need for precise diagnostic and procedural guidance. Modalities include transthoracic and transesophageal echocardiography, cardiac computed tomography and fluoroscopy with 3D mapping, and more. Why it matters: The ability to see the heart accurately means less risk and better results during a procedure. Transcatheter therapies, including transcatheter aortic valve replacement and edge-to-edge mitral repair, have gone from experimental to standard of care over the last 20 years, leading to increased adoption and vendors to develop high-resolution 3D fusion solutions.
Advances in imaging technology and analytics to perform safer and more complex transcatheter interventions will be the main driver of growth, riding on the clinical momentum. High fidelity CT and real time 3D echocardiography enable accurate annular sizing and spatial orientation to facilitate expansion of indications, increasing procedure volumes and stimulating demand for integrated imaging platforms. Fusion imaging for catheter navigation in hybrid operating rooms reduces procedural times and complication rates and creates willingness of payers to reimburse novel interventions. Looking forward, automated measurements and cloud-based image sharing using artificial intelligence will further reduce workflow friction and opportunities in emerging markets.
How is AI enhancing diagnostic accuracy in the structural heart imaging market?
In the structural heart imaging market, AI is improving diagnostic accuracy by automating image segmentation, standardizing views, and integrating multimodality data to reveal subtle anatomy and function. Key features include machine learning models to reduce observer variability and visual decision support to highlight potential pathologies. Clinical adoption is increasing in the current state as algorithms are incorporated into echo and CT workflows to aid in planning for procedures such as valve replacement and mitral repair. Multiview and multimodal AI techniques have been shown to improve detection over single view models. Imaging consoles are incorporating AI-powered quantifications and workflow tools to improve consistency and efficiency.
Siemens Healthineers May 2026, received FDA clearance for new AI powered interventional imaging systems called Optiq AI that enhance image quality and assist in guiding procedures. This innovation helps to accelerate diagnostic confidence, streamline procedural workflows through automated quantification and provide enhanced real time imaging to support growth in the market.
Market snapshot - (2026-2033)
Global Market Size
USD 9.5 Billion
Largest Segment
Imaging Systems
Fastest Growth
Software
Growth Rate
7.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global structural heart imaging market is segmented by component, imaging modality, technology, application, end user and region. Based on component, the market is segmented into Imaging Systems, Software and Services. Based on imaging modality, the market is segmented into Echocardiography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Fluoroscopy, Nuclear Imaging and Others. Based on technology, the market is segmented into 2D Imaging, 3D/4D Imaging, Fusion Imaging, AI-Assisted Imaging and Others. Based on application, the market is segmented into Transcatheter Valve Procedures, Congenital Heart Disease, Left Atrial Appendage Closure, Heart Failure Assessment and Others. Based on end user, the market is segmented into Hospitals, Cardiac Centers, Diagnostic Imaging Centers, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The echo piece is special because it gives you a way to look at valve and structural problems at the bedside, in real time, and this information is used directly to decide on procedures and to select patients for transcatheter therapies. Its preferred use is due to high clinician familiarity, portability of systems, and compatibility with interventional workflows. These benefits decrease procedural uncertainty, optimize imaging to treatment pathways, and support broad integration throughout hospitals and cardiac centers, ensuring its central position in the structural heart imaging market.
However, Computed Tomography (CT) is emerging as the fastest growing modality due to advanced volumetric acquisition, high resolution anatomical mapping and increasing adoption for pre procedural device sizing and 3D model generation. The improved scanner technology and expanding clinical guidelines are accelerating demand, unlocking new procedural planning workflows and commercial opportunities across imaging and device ecosystems.
3D/4D The imaging segment is the dominant segment as immersive volumetric visualization directly translates into more accurate anatomical assessment, device sizing and intra procedural guidance for complex structural interventions. Better visualization reduces procedure time and uncertainty, integrates with navigation platforms, allows for multidisciplinary planning, and enables closer collaboration with device manufacturers and simulation vendors. These operational efficiencies and increased clinical confidence are driving widespread adoption among interventional teams and imaging providers in the structural heart imaging market.
AI Assisted Imaging, on the other hand, is enjoying strong growth momentum as machine learning automates complex measurements, standardizes reporting and accelerates detection of subtle structural changes. Adoption is driven by regulatory approval of strong algorithms and by the incorporation of modalities into multimodality workflows to enable scalable diagnostics, reduce burden on clinicians, and build commercial opportunities across the structural heart imaging ecosystem.
To get detailed segments analysis, Request a Free Sample Report
North America is at the forefront of the global structural heart imaging market due to a blend of advanced clinical capabilities, heightened research activity, and robust private sector engagement. Sophisticated hospital systems and networks of specialized cardiac centers offer the procedural volume and multidisciplinary expertise required to facilitate complex imaging workflows and device guided interventions. A strong collaborative innovation ecosystem between medical device companies, imaging vendors and academic centers is conducive to faster product development and clinical validation. Reimbursement structures and existing health technology assessment processes facilitate the adoption of comprehensive imaging protocols into care pathways. High clinician expertise, broad training opportunities, and established centers of excellence also support leadership, allowing quick uptake of new modalities and close alignment between imaging innovations and interventional cardiology needs.
The United States Structural Heart Imaging Market is driven by advanced clinical infrastructure, clinical expertise and collaboration between device developers and imaging providers. High procedural volumes at specialized centers enable standardization of protocols and comfort with complex imaging workflows for clinicians. Integrated reimbursement pathways, private sector investment and partnerships help to improve technology iteratively. Collaborations of academia with industry promote evidence generation and adoption. The market is poised to lead in device-guided imaging and multidisciplinary care.
The structural heart imaging market in Canada is defined by a well-coordinated public health system, strong academic hospitals, and a dedication to equitable access to leading-edge cardiac care. Centers of excellence in regions. Multidisciplinary teams integrate imaging with interventional planning. Collaborative networks promote education and best practices. Health technology assessment frameworks and provider focus on clinical value resulting in uptake of evidence-based imaging strategies and alignment of clinical needs and innovation.
Europe is experiencing rapid growth in structural heart imaging, supported by coordinated regulatory pathways, strong clinical research networks and a growing need for minimally invasive cardiac interventions. The existence of strong specialized centers, as well as collaborative consortia that cross public and private institutions, allows for multicenter evidence generation and technology validation. As health technology assessment and payer engagement increasingly emphasize clinical value, providers are turning to advanced imaging for procedural planning and follow up. Cross border knowledge exchange, initiatives to train clinicians, active participation from established medical device companies and opportunities for wider diffusion of imaging modalities and integrated care models in emerging markets within the region support faster adoption in mature health systems. Investment in training and center accreditation programs, as well as targeted efforts to optimize cross disciplinary workflows, enhances procedural efficiency and clinician confidence with advanced modalities.
The Structural Heart Imaging Market in Germany is supported by a strong network of tertiary cardiac centers, strong medtech base and clinical research infrastructure. Multidisciplinary teams and specialized imaging laboratories support complex procedural planning and device implantation, and hospital pathways developed to allow the systematic integration of advanced imaging into routine care. Collaborative trials and industry partnerships encourage the adoption of global technologies and create a favorable environment for clinical validation and training.
The Structural Heart Imaging Market in the UK is characterized by fast adoption pathways, Centres of Excellence, and public-private partnerships that accelerate clinical research and deployment. National clinician training and certification help propagate best practices across cardiac centers. A vibrant medtech ecosystem partners with academic hospitals to validate imaging solutions. Flexible funding and clinician leadership allows advanced imaging to be integrated into interventional workflows, care pathways and cross discipline coordination efforts.
France’s structural heart imaging market is budding due to investments in cardiac imaging capabilities, the growing expertise within hospitals and collaborations between clinical networks and industry partners. Tertiary centers are developing imaging programs focusing on evidence based integration with interventional services. Clinical value is increasingly driving health authority engagement and hospital procurement processes toward the use of advanced modalities. Dissemination and broader market development are supported by training initiatives and regional centers of excellence.
The Asia Pacific is cementing its place in the structural heart imaging market by enhancing clinical capabilities, investing in imaging technologies and fostering increased collaboration between local manufacturers and global partners. Major tertiary hospitals and specialized cardiac centers in key markets are also upgrading their imaging infrastructure and clinician training to support more complex procedural planning and device-guided interventions. Technology adoption is being driven by regulatory modernization and a greater focus on minimally invasive therapies by health systems. Fostering domestic innovation in imaging equipment and software, along with targeted training programs and regional clinical networks, is helping to translate global advances into locally relevant solutions and broader access across diverse health systems. Hospitals are adopting advanced imaging workflows as private sector investment grows and reimbursement considerations change. Cross border academic collaborations and telemedicine capabilities further allow dissemination of expertise and scalable implementation across the region.
The Structural Heart Imaging Market in Japan is driven by high level of clinician expertise, advanced hospital infrastructure, and collaboration between domestic technology companies and academic centers. Investment into imaging modalities and software integration enables comprehensive procedural planning at specialized cardiac units. Regulatory pathways and clinical research programs to facilitate iterative testing and refinement of imaging solutions. Sophisticated imaging will be incorporated into routine interventional cardiology practice with the help of training and cross disciplinary collaboration.
South Korea Structural Heart Imaging Market is growing on the back of strong hospital networks, technology uptake and partnerships between medtech companies and clinicians. Tertiary centers incorporate advanced imaging into procedural workflows through focused training and clinical partnerships. A positive innovation climate promotes the development of compatible imaging software and device solutions, while research collaborations and pilot programs demonstrate their use in minimally invasive interventions, thus enhancing local capacity and facilitating wider clinical use.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Prevalence Of Cardiac Conditions
Technological Advancements In Imaging Modalities
High Capital Expenditure Requirements
Regulatory Complexity and Reimbursement Policies
Request Free Customization of this report to help us to meet your business objectives.
Companies are competing in structural heart imaging through regulatory clearances, OEM and hospital partnerships, targeted M&A, and product commercialization to win cath lab integration. These include iCardio.ai’s regulatory progress and Abbott collaboration, Visura’s Series B commercialization push for TEECAD, and Echo IQ’s FDA clearance for EchoSolv, as firms compete on device compatibility and workflow embedding.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global structural heart imaging market is poised for steady growth driven primarily by the rising prevalence of valvular and congenital cardiac conditions, with technological advancements in imaging hardware and analytics acting as a second major driver. Adoption is led by North America where advanced clinical infrastructure, reimbursement support and concentrated research accelerate uptake, while 3D/4D imaging dominates as the preferred segment for procedural planning and intraprocedural guidance. However high capital expenditure requirements for advanced systems remain a key restraint that can slow diffusion to smaller hospitals and emerging markets. Integrated AI assisted fusion imaging and cloud based image sharing are expected to further streamline workflows and expand use cases.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 9.5 Billion |
| Market size value in 2033 | USD 17.76 Billion |
| Growth Rate | 7.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Structural Heart Imaging Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Structural Heart Imaging Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Structural Heart Imaging Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Structural Heart Imaging Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Structural Heart Imaging Market size was valued at USD 9.5 Billion in 2024 and is poised to grow from USD 10.18 Billion in 2025 to USD 17.76 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
Competitive dynamics in structural heart imaging are driven by incumbents and AI entrants using regulatory clearances, OEM and hospital partnerships, targeted M&A, and product commercialization to win cath lab integration; examples include iCardio.ai’s regulatory progress and Abbott collaboration, Visura’s Series B commercialization push for TEECAD, and Echo IQ’s FDA clearance for EchoSolv as firms compete on device compatibility and workflow embedding. 'GE HealthCare Technologies Inc.', 'Siemens Healthineers AG', 'Philips Healthcare', 'Canon Medical Systems Corporation', 'Fujifilm Holdings Corporation', 'Hitachi, Ltd.', 'Samsung Medison Co., Ltd.', 'Esaote S.p.A.', 'HeartFlow, Inc.', 'Circle Cardiovascular Imaging Inc.', 'Pie Medical Imaging B.V.', 'TomTec Imaging Systems GmbH', 'Viz.ai, Inc.', 'Terarecon, Inc.', 'Medis Medical Imaging Systems BV', 'Arterys Inc.', 'Ultromics Limited', 'Caristo Diagnostics Ltd.', 'Bay Labs, Inc.', 'NeoSoft LLC'
Growing incidence of cardiovascular diseases has expanded demand for advanced structural heart imaging by increasing the clinical need to accurately diagnose and monitor complex cardiac anatomies. Improved detection requirements drive hospitals and specialist centers to adopt sophisticated imaging modalities to guide interventional procedures and longitudinal care. Clinicians increasingly rely on high resolution visualization to plan therapies and assess outcomes, prompting procurement of compatible imaging platforms and software. This sustained clinical imperative directly supports market expansion through consistent institutional investment and prioritization of imaging capabilities.
Advanced Multimodal Integration: Growing demand for integrated structural heart imaging workflows is driving closer coupling of echocardiography, CT and MRI data into unified platforms that enhance procedural guidance and diagnostic confidence. Vendors emphasize software interoperability, real time image fusion, and streamlined user interfaces to reduce procedural complexity and improve clinician collaboration. This trend supports expanded adoption across hospitals and specialized centers, encourages partnerships between imaging and device companies, and stimulates investment in training and service models that optimize patient pathway efficiency and outcomes.
Why does North America Dominate the Global Structural Heart Imaging Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
